Blog
  by

Virtual Health Limits Spread of Disease During Epidemic Flu Season

This year’s flu season has been particularly bad, with the CDC officially stating that it has reached “epidemic” levels. Unfortunately, as has been widely reported, this year’s flu shot was only 10% effective against a widespread  strain of flu that is particularly difficult to treat with a flu shot. As hospital emergency departments and urgent care centers become overrun with flu patients, concerns of spreading the illness due to proximity are resulting in hospitals turning to virtual health to potentially reduce its spread. In some areas, virtual visits for flu treatment  have doubled from normal levels, slowing the spread of the illness and allowing hospitals to focus on severe flu cases that require emergent care.

In addition to providing clinical value, virtual technology is being used to track the flu. Kinsa Inc, a health technology company, uses “smart thermometers” to track temperatures across the country and identify which areas of the country are most severely affected by the flu epidemic. With its smart thermometers owned by more than 500,000 US households, the company receives approximately 25,000 readings per day, allowing it to almost instantaneously identify fever spikes in states and cities across the nation. This information can enable public health officials and health systems to more effectively deploy additional resources to areas of need.

Don’t have a virtual health offering to provide flu treatment or other services for your patient population ? Refer to Sg2’s Virtual Health Starter Kit to learn how virtual health can play an important role in your organization’s strategy. Not an Sg2 member? Contact us to learn more.

 

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube